| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Regulatory Affairs | SVP, Regulatory Affairs &Qual
1 company
Ruff Shamim is a SVP, Chief Regulatory Affairs at Sarepta Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $587K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2017 | SRPT Sarepta Therapeutics, Inc. | SVP, Regulatory Affairs &Qual | Sale+OE | 10,000 | $55.00 | $550,000.00 | -27.0% | |
| Oct 3, 2017 | SRPT Sarepta Therapeutics, Inc. | SVP, Regulatory Affairs &Qual | Sale+OE | 11,500 | $50.00 | $575,000.00 | -29.8% | |
| Jul 21, 2017 | SRPT Sarepta Therapeutics, Inc. | SVP, Regulatory Affairs &Qual | Sale+OE | 12,138 | $42.97 | $521,572.00 | -16.1% | |
| Sep 22, 2016 | SRPT Sarepta Therapeutics, Inc. | SVP, Regulatory Affairs &Qual | Sale+OE | 7,311 | $60.00 | $438,660.00 | -26.5% |